These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8810995)

  • 21. Thiol suppression of human immunodeficiency virus type 1 replication in primary cord blood monocyte-derived macrophages in vitro.
    Lioy J; Ho WZ; Cutilli JR; Polin RA; Douglas SD
    J Clin Invest; 1993 Feb; 91(2):495-8. PubMed ID: 7679409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.
    Michaelis M; Suhan T; Reinisch A; Reisenauer A; Fleckenstein C; Eikel D; Gümbel H; Doerr HW; Nau H; Cinatl J
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3451-7. PubMed ID: 16123451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection of human macrophages with an endogenous tumour necrosis factor-alpha (TNF-alpha)-independent human immunodeficiency virus type 1 isolate is unresponsive to the TNF-alpha synthesis inhibitor RP 55778.
    Le Naour R; Clayette P; Henin Y; Mabondzo A; Raoul H; Bousseau A; Dormont D
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1379-88. PubMed ID: 7515938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication.
    Raju PA; Herzenberg LA; Herzenberg LA; Roederer M
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):961-7. PubMed ID: 7811547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
    Popik W; Pitha PM
    Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors.
    Cushman M; Casimiro-Garcia A; Hejchman E; Ruell JA; Huang M; Schaeffer CA; Williamson K; Rice WG; Buckheit RW
    J Med Chem; 1998 Jun; 41(12):2076-89. PubMed ID: 9622549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage.
    Poli G; Kinter AL; Justement JS; Bressler P; Kehrl JH; Fauci AS
    J Exp Med; 1991 Mar; 173(3):589-97. PubMed ID: 1705278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An in vitro approach to assess the neurotoxicity of valproic acid-induced oxidative stress in cerebellum and cerebral cortex of young rats.
    Chaudhary S; Parvez S
    Neuroscience; 2012 Dec; 225():258-68. PubMed ID: 22960313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide.
    Jiménez JL; González-Nicolás J; Alvarez S; Fresno M; Muñoz-Fernández MA
    J Virol; 2001 May; 75(10):4655-63. PubMed ID: 11312336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid.
    Michaelis M; Köhler N; Reinisch A; Eikel D; Gravemann U; Doerr HW; Nau H; Cinatl J
    Biochem Pharmacol; 2004 Aug; 68(3):531-8. PubMed ID: 15242819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cAMP stimulates human immunodeficiency virus (HIV-1) from latently infected cells of monocyte-macrophage lineage: synergism with TNF-alpha.
    Chowdhury MI; Koyanagi Y; Horiuchi S; Hazeki O; Ui M; Kitano K; Golde DW; Takada K; Yamamoto N
    Virology; 1993 May; 194(1):345-9. PubMed ID: 7683159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist.
    Poli G; Kinter AL; Fauci AS
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):108-12. PubMed ID: 7506410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of herpes virus infection in oligodendrocyte cultured cells by valproic acid.
    Crespillo AJ; Praena B; Bello-Morales R; Lerma L; Vázquez-Calvo A; Martín-Acebes MA; Tabarés E; Sobrino F; López-Guerrero JA
    Virus Res; 2016 Mar; 214():71-9. PubMed ID: 26805038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-12 decreases human immunodeficiency virus type 1 replication in human macrophage cultures reconstituted with autologous peripheral blood mononuclear cells.
    Akridge RE; Reed SG
    J Infect Dis; 1996 Mar; 173(3):559-64. PubMed ID: 8627017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophages.
    Hanley TM; Kiefer HL; Schnitzler AC; Marcello JE; Viglianti GA
    J Virol; 2004 Mar; 78(6):2819-30. PubMed ID: 14990701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism.
    Peterson PK; Gekker G; Chao CC; Hu SX; Edelman C; Balfour HH; Verhoef J
    J Clin Invest; 1992 Feb; 89(2):574-80. PubMed ID: 1310698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cellular differentiation on cytokine-induced expression of human immunodeficiency virus in chronically infected promonocytic cells: dissociation of cellular differentiation and viral expression.
    Goletti D; Kinter AL; Biswas P; Bende SM; Poli G; Fauci AS
    J Virol; 1995 Apr; 69(4):2540-6. PubMed ID: 7884904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A.
    Hayes MM; Lane BR; King SR; Markovitz DM; Coffey MJ
    Cell Immunol; 2002 Jan; 215(1):61-71. PubMed ID: 12142037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human immunodeficiency virus type 1 replication in acutely and chronically infected cells by EM2487, a novel substance produced by a Streptomyces species.
    Baba M; Okamoto M; Takeuchi H
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2350-5. PubMed ID: 10508005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells.
    Fazely F; Dezube BJ; Allen-Ryan J; Pardee AB; Ruprecht RM
    Blood; 1991 Apr; 77(8):1653-6. PubMed ID: 1707692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.